{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:22:48Z","timestamp":1790234568690,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T00:00:00Z","timestamp":1566864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1038\/s41409-019-0632-z","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T17:02:55Z","timestamp":1566925375000},"page":"974-978","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intra-bone donor lymphocyte infusion at relapse: clinical outcome is associated with presence of CD8+ cells in the marrow"],"prefix":"10.1038","volume":"55","author":[{"given":"Andrzej","family":"Lange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Wodzi\u0144ska-Maszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sobczy\u0144ska-Konefa\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Mordak-Domaga\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Boche\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Jasku\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,27]]},"reference":[{"key":"632_CR1","unstructured":"Kharfan-Dabaja MA, Labopin M, Polge E, Nishihori T, Bazarbachi A, Finke J, et al. Adoptive cellular therapy with donor lymphocyte infusion versus a second allogeneic hematopoietic cell transplant for post-allograft relapsed acute myeloid leukemia: an intent-to-treat analysis on behalf of the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT). Blood. 2017;130(Suppl 1):273."},{"key":"632_CR2","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1634\/stemcells.2006-0234","volume":"25","author":"J Fukui","year":"2007","unstructured":"Fukui J, Inaba M, Ueda Y, Miyake T, Hosaka N, Kwon A-H, et al. Prevention of graft-versus-host disease by intra-bone marrow injection of donor T cells. Stem Cells. 2007;25:1595\u2013601.","journal-title":"Stem Cells."},{"key":"632_CR3","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","volume":"124","author":"A Gros","year":"2014","unstructured":"Gros A, Robbins PF, Yao X, Li YF, Turcotte S, Tran E, et al. PD-1 identifies the patient-specific infiltrating human tumors. J Clin Invest. 2014;124:2246\u201359.","journal-title":"J Clin Invest."},{"key":"632_CR4","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1158\/0008-5472.CAN-04-3337","volume":"65","author":"K Noonan","year":"2005","unstructured":"Noonan K, Matsui W, Serafini P, Carbley R, Tan G, Khalili J, et al. Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors. Cancer Res. 2005;65:2026\u201334.","journal-title":"Cancer Res"},{"key":"632_CR5","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1001\/jamaoncol.2018.2091","volume":"4","author":"MA Kharfan-Dabaja","year":"2018","unstructured":"Kharfan-Dabaja MA, Labopin M, Polge E, Nishihori T, Bazarbachi A, Finke J, et al. Association of second allogeneic hematopoietic cell transplant vs donor lymphocyte infusion with overall survival in patients with acute myeloid leukemia relapse. JAMA Oncol. 2018;4:1245.","journal-title":"JAMA Oncol."},{"key":"632_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2217\/imt.13.31","volume":"5","author":"N El-Jurdi","year":"2013","unstructured":"El-Jurdi N, Reljic T, Kumar A, Pidala J, Bazarbachi A, Djulbegovic B, et al. Efficacy of adoptive immunotherapy with donor lymphocyte infusion in relapsed lymphoid malignancies. Immunotherapy. 2013;5:457\u201366.","journal-title":"Immunotherapy."},{"key":"632_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/bmt.2011.45","volume":"47","author":"J Hasskarl","year":"2012","unstructured":"Hasskarl J, Zerweck A, W\u00e4sch R, Ihorst G, Bertz H, Finke J. Induction of graft versus malignancy effect after unrelated allogeneic PBSCT using donor lymphocyte infusions derived from frozen aliquots of the original graft. Bone Marrow Transplant. 2012;47:277\u201382.","journal-title":"Bone Marrow Transplant."},{"key":"632_CR8","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.4049\/jimmunol.1302064","volume":"192","author":"OV Britanova","year":"2014","unstructured":"Britanova OV, Putintseva EV, Shugay M, Merzlyak EM, Turchaninova MA, Staroverov DB, et al. Age-related decrease in TCR repertoire diversity measured with deep and normalized sequence profiling. J Immunol. 2014;192:2689\u201398.","journal-title":"J Immunol."},{"key":"632_CR9","unstructured":"Gielis S, Moris P, Neuter N De, Bittremieux W, Ogunjimi B, Laukens K, et al. TCRex: a webtool for the prediction of T-cell receptor sequence epitope specificity. bioRxiv. 2018;373472."},{"key":"632_CR10","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H D\u00f6hner","year":"2017","unstructured":"D\u00f6hner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, B\u00fcchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017;129:424\u201347.","journal-title":"Blood"},{"key":"632_CR11","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, D\u00f6hner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood 2018;131:2745\u201360.","journal-title":"Blood"},{"key":"632_CR12","doi-asserted-by":"publisher","first-page":"e28187","DOI":"10.4161\/onci.28187","volume":"3","author":"P Bachireddy","year":"2014","unstructured":"Bachireddy P, Wu CJ. Understanding anti-leukemia responses to donor lymphocyte infusion. Oncoimmunology 2014;3:e28187.","journal-title":"Oncoimmunology"},{"key":"632_CR13","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2013-08-523001","volume":"123","author":"P Bachireddy","year":"2014","unstructured":"Bachireddy P, Hainz U, Rooney M, Pozdnyakova O, Aldridge J, Zhang W, et al. Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. Blood 2014;123:1412\u201321.","journal-title":"Blood"},{"key":"632_CR14","doi-asserted-by":"publisher","first-page":"e0190525","DOI":"10.1371\/journal.pone.0190525","volume":"13","author":"A Lange","year":"2018","unstructured":"Lange A, Jaskula E, Lange J, Dworacki G, Nowak D, Simiczyjew A, et al. The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow. PLoS ONE 2018;13:e0190525.","journal-title":"PLoS ONE"},{"key":"632_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrc3237","volume":"12","author":"M Vanneman","year":"2012","unstructured":"Vanneman M, Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer 2012;12:237\u201351.","journal-title":"Nat Rev Cancer"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0632-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0632-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-019-0632-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:15:17Z","timestamp":1684617317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-019-0632-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,27]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1038\/s41409-019-0632-z","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,27]]},"assertion":[{"value":"4 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}